EXHIBIT 4.6 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of March 23, 1999, is by and between Sepracor Inc., a Delaware corporation ("Sepracor"), and HemaSure Inc., a Delaware corporation (the...Registration Rights Agreement • April 1st, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 1st, 1999 Company Industry Jurisdiction
Exhibit 10.31 FORM OF PURCHASE AGREEMENT HEMASURE INC. March 2, 2000 HEMASURE INC. PURCHASE AGREEMENT This Purchase Agreement (the "Agreement") is made as of the __ day of March, 2000 (the "Agreement Date"), by and between HemaSure Inc., a Delaware...Purchase Agreement • March 30th, 2000 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 30th, 2000 Company Industry Jurisdiction
Exhibit 10.05 FORM OF WARRANT --------------- Warrant No. --- THIS WARRANT (AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN...Warrant Agreement • May 15th, 2002 • Point Therapeutics Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMay 15th, 2002 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 9th, 2012 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 9th, 2012 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 6, 2012, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
HEMASURE INC. andStockholders' Agreement • May 17th, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 17th, 1999 Company Industry Jurisdiction
EXHIBIT 4.7 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this "Agreement"), dated as of March 23, 1999 is by and between HEMASURE INC., a Delaware corporation ("HemaSure"), and SEPRACOR INC., a Delaware corporation (the "Holder"). W I T N E S S E T H:...Warrant Agreement • April 1st, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 1st, 1999 Company Industry Jurisdiction
RECITALS:Agreement and Plan of Merger • December 18th, 2007 • Point Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledDecember 18th, 2007 Company Industry
COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.Security Agreement • February 12th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 12th, 2014 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February__________, 2014 (the “Initial Exercise Date”) and on or prior to the close of business on February __________, 20191 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 10.33 SETTLEMENT AGREEMENT 1. Parties HemaSure Inc., 140 Locke Drive, Marlborough, MA 01752-1146, USA ("HemaSure") and HemaSure AB, reg.no. 556307-7311, c/o Lagerlof & Leman, Box 5402, S-114 84 Stockholm, Sweden, hereinafter jointly referred...Settlement Agreement • March 31st, 1998 • Hemasure Inc • Surgical & medical instruments & apparatus
Contract Type FiledMarch 31st, 1998 Company Industry
Exhibit 4.3 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (the "Agreement"), dated as of September 15, 1998, by and between Sepracor Inc., a Delaware corporation ("Sepracor"), and HemaSure Inc., a Delaware corporation (the "Company")....Registration Rights Agreement • November 16th, 1998 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledNovember 16th, 1998 Company Industry Jurisdiction
EXHIBIT 10.33 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this "Agreement") is made this 23 day of March, 1999 by and between Hemasure Inc., a Delaware corporation (the "Company"), and Sepracor Inc., a Delaware corporation (the...Securities Purchase Agreement • April 1st, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 1st, 1999 Company Industry Jurisdiction
ANDWarrant Agreement • November 16th, 1998 • Hemasure Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledNovember 16th, 1998 Company Industry Jurisdiction
Exhibit 10.03 EMPLOYMENT, CONFIDENTIALITY AND NON-COMPETITION AGREEMENT ----------------------------- THIS EMPLOYMENT, CONFIDENTIALITY AND NON- COMPETITION AGREEMENT (the "Agreement") is made and entered into this 26th day of September, 2001 (the...Employment Agreement • May 15th, 2002 • Point Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledMay 15th, 2002 Company Industry Jurisdiction
Exhibit 10.17 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (hereafter referred to as this "Agreement") is made by and between Point Therapeutics, Inc, a Delaware corporation, (the "Company") and Margaret J. Uprichard, Pharm.D....Executive Employment Agreement • March 31st, 2003 • Point Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledMarch 31st, 2003 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 30th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 30th, 2014 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 30, 2014 (the “Effective Date”), between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ARTICLE I DEFINITIONSManufacturing Agreement • March 30th, 2000 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 30th, 2000 Company Industry Jurisdiction
COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.Common Stock Purchase Warrant • May 30th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations
Contract Type FiledMay 30th, 2014 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _______, 2014 (the “Initial Exercise Date”)1 and on or prior to the close of business on _________, 20192 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
HEMASURE INC.Convertible Note • March 31st, 1997 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 31st, 1997 Company Industry Jurisdiction
HEMASURE INC.Registration Rights Agreement • March 31st, 1997 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 31st, 1997 Company Industry Jurisdiction
BETWEEN HEMASURE INC. ANDIntellectual Property Security Agreement • November 16th, 1998 • Hemasure Inc • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledNovember 16th, 1998 Company Industry Jurisdiction
Exhibit 10.33 INDEMNIFICATION AGREEMENT ------------------------- This Agreement is made as of the 13th day of July, 2000, by and between Ahlstrom Technical Specialties LLC, a Delaware limited liability company ("Ahlstrom"), and HemaSure Inc., a...Indemnification Agreement • August 11th, 2000 • Hemasure Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledAugust 11th, 2000 Company Industry Jurisdiction
SUMMIT ROUNDTABLEConsulting Agreement • November 14th, 2001 • HMSR Inc • Surgical & medical instruments & apparatus
Contract Type FiledNovember 14th, 2001 Company Industry
ContractSecurities Purchase Agreement • April 18th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 18th, 2014 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of _______, 2014 (the “Effective Date”), between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 26th, 2010 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 26th, 2010 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October , 2010, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Exhibit 10.1 RESTRUCTURING AGREEMENT THIS RESTRUCTURING AGREEMENT (the "Agreement"), dated January 23, 1997, is made and entered into by and among HemaSure Inc., a Delaware corporation with its principle place of business at 140 Locke Drive,...Restructuring Agreement • February 27th, 1997 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 27th, 1997 Company Industry Jurisdiction
Mr. Richard A. Franco, Sr. Chief Executive Officer DARA BioSciences, Inc.Placement Agent Agreement • September 14th, 2009 • DARA BioSciences, Inc. • Pharmaceutical preparations • Georgia
Contract Type FiledSeptember 14th, 2009 Company Industry Jurisdiction
EMPLOYMENT AGREEMENT --------------------Employment Agreement • November 14th, 2001 • HMSR Inc • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledNovember 14th, 2001 Company Industry Jurisdiction
COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.Common Stock Purchase Warrant • May 22nd, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations
Contract Type FiledMay 22nd, 2014 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _______, 2014 (the “Initial Exercise Date”) 1 and on or prior to the close of business on _________, 2019 2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
HEMASURE INC.Placement Agency Agreement • March 30th, 2000 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 30th, 2000 Company Industry Jurisdiction
Exhibit 10.16 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (hereafter referred to as this "Agreement") is made by and between Point Therapeutics, Inc, a Delaware corporation, (the "Company") and Barry Jones, Ph.D. (the...Executive Employment Agreement • March 31st, 2003 • Point Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledMarch 31st, 2003 Company Industry Jurisdiction
AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN HEMASURE INC. AND COBE LABORATORIES, INC.Exclusive Distribution Agreement • May 17th, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 17th, 1999 Company Industry Jurisdiction
EXHIBIT 10.37 TERMINATION AND RELEASE AGREEMENT This Agreement, effective the 5th day of March, 2001 (the "Effective Date"), by and between HemaSure Inc. ("HemaSure"), a Delaware corporation having a principal place of business at 140 Locke Drive,...Termination and Release Agreement • March 26th, 2001 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 26th, 2001 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 29th, 2010 • DARA BioSciences, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledDecember 29th, 2010 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 29, 2010, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 2nd, 2007 • Point Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 2nd, 2007 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 1, 2007, among Point Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 1st, 2004 • Point Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 1st, 2004 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) is made and entered into as of March 24, 2004, by and among Point Therapeutics, Inc., a Delaware corporation (the “Company”), and the investors signatory hereto (each a “Investor” and collectively, the “Investors”).